Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

Cancer Epidemiology Biomarkers and Prevention

Volumn 19, Issue 11, 2010, Pages 2859-2868

  Engel, Christoph ^a   Versmold, Beatrix ^b   Wappenschmidt, Barbara ^b   Simard, Jacques ^c   Easton, Douglas F ^d   Peock, Susan ^d   Cook, Margaret ^d   Oliver, Clare ^d   Frost, Debra ^d   Mayes, Rebecca ^d   Evans, D Gareth ^e   Eeles, Rosalind ^f   Paterson, Joan ^g   Brewer, Carole ^h   McGuffog, Lesley ^d   Antoniou, Antonis C ^d   Stoppa Lyonnet, Dominique ⁱ   Sinilnikova, Olga M ^j   Barjhoux, Laure ^k   Frenay, Marc ^l   Michel, Cécile ^l   Leroux, Dominique ^m   Dreyfus, Helene ^m   Toulas, Christine ⁿ   Gladieff, Laurence ⁿ   Uhrhammer, Nancy ^o   Bignon, Yves Jean ^o   Meindl, Alfons ^p   Arnold, Norbert ^q   Varon Mateeva, Raymonda ^r   Niederacher, Dieter ^s   Preisler Adams, Sabine ^t   Kast, Karin ^u   Deissler, Helmut ^v   Sutter, Christian ^w   Gadzicki, Dorothea ^x   Chenevix Trench, Georgia ^y   Spurdle, Amanda B ^y   Chen, Xiaoqing ^y   Beesley, Jonathan ^y   Olsson, Håkan ^z   Kristoffersson, Ulf ^z   Ehrencrona, Hans ^aa   Liljegren, Annelie ^ab   Van Der Luijt, Rob B ^ac   Van Os, Theo A ^ad   Van Leeuwen, Flora E ^ae   Domchek, Susan M ^af   Rebbeck, Timothy R ^af   Nathanson, Katherine L ^af   Osorio, Ana ^ag,ah   Ramón Y Cajal, Teresa ^ai   Konstantopoulou, Irene ^aj   Benítez, Javier ^ag,ah   Friedman, Eitan ^ak   Kaufman, Bella ^al   Laitman, Yael ^ak   Mai, Phuong L ^am   Greene, Mark H ^am   Nevanlinna, Heli ^an   Aittomäki, Kristiina ^an   Szabo, Csilla I ^ao   Caldes, Trinidad ^ap   Couch, Fergus J ^aq   Andrulis, Irene L ^ar   Godwin, Andrew K ^as   Hamann, Ute ^at   Schmutzler, Rita K ^b   more..

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c LAVAL UNIVERSITY   (Canada)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

^f INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^g ADDENBROOKE S HOSPITAL   (United Kingdom)

^h ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

ⁱ INSERM   (France)

^j HOSPICES CIVILS DE LYON   (France)

^k UNIVERSITÉ DE LYON   (France)

^l CENTRE ANTOINE LACASSAGNE   (France)

^m GRENOBLE UNIVERSITY HOSPITAL   (France)

ⁿ INSTITUT CLAUDIUS REGAUD   (France)

^o CENTRE JEAN PERRIN   (France)

^p TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^q UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^r CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^s HEINRICH HEINE UNIVERSITY   (Germany)

^t UNIVERSITY OF MÜNSTER   (Germany)

^u DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^v UNIVERSITY OF ULM   (Germany)

^w UNIVERSITY OF HEIDELBERG   (Germany)

^x HANNOVER MEDICAL SCHOOL   (Germany)

^y QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^z LUND UNIVERSITY   (Sweden)

^aa UPPSALA UNIVERSITY   (Sweden)

^ab KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^ac UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^ad ACADEMIC MEDICAL CENTER   (Netherlands)

^ae NETHERLANDS CANCER INSTITUTE   (Netherlands)

^af UNIVERSITY OF PENNSYLVANIA   (United States)

^ag Centro Nacional de Investigaciones Oncológicas   (Spain)

^ah CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^ai HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^aj INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^ak GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^al SHEBA MEDICAL CENTER   (Israel)

^am NATIONAL CANCER INSTITUTE   (United States)

^an HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^ao Mayo Clinic   (United States)

^ap HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^aq MAYO CLINIC   (United States)

^ar MOUNT SINAI HOSPITAL   (Canada)

^as FOX CHASE CANCER CENTER   (United States)

^at GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; CASPASE 10; CASPASE 8;

ADULT; ALLELE; ARTICLE; BREAST CANCER; CANCER RISK; DNA POLYMORPHISM; FEMALE; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL;

BREAST NEOPLASMS; CASPASE 10; CASPASE 8; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MUTATION; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 78549237225     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-0517     Document Type: Article

References (32)

1. Hengartner MO. The biochemistry of apoptosis. Nature 2000;407:770-6.
2. Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature 2001;411:342-8.
3. Siegel RM. Caspases at the crossroads of immune-cell life and death. Nat Rev Immunol 2006;6:308-17.
4. Park WS, Lee JH, Shin MS, et al. Inactivating mutations of the caspase-10 gene in gastric cancer. Oncogene 2002;21:2919-25.
5. Kim HS, Lee JW, Soung YH, et al. Inactivating mutations of caspase-8 gene in colorectal carcinomas. Gastroenterology 2003;125:708-15.
6. Soung YH, Lee JW, Kim SY, et al. CASPASE-8 gene is inactivated by somatic mutations in gastric carcinomas. Cancer Res 2005;65:815-21.
7. MacPherson G, Healey CS, Teare MD, et al. Association of a common variant of the CASP8 gene with reduced risk of breast cancer. J Natl Cancer Inst 2004;96:1866-9.
8. Imyanitov E, Hanson K, Zhivotovsky B. Polymorphic variations in apoptotic genes and cancer predisposition. Cell Death Differ 2005;12:1004-7. (Pubitemid 41065417)
9. Frank B, Bermejo JL, Hemminki K, et al. Re: Association of a common variant of the CASP8 gene with reduced risk of breast cancer. J Natl Cancer Inst 2005;97:1012, author reply 1012-3.
10. Frank B, Hemminki K, Wappenschmidt B, et al. Association of the CASP10 V410I variant with reduced familial breast cancer risk and interaction with the CASP8 D302H variant. Carcinogenesis 2006;27:606-9.
11. Son JW, Kang HK, Chae MH, et al. Polymorphisms in the caspase-8 gene and the risk of lung cancer. Cancer Genet Cytogenet 2006;169:121-7.
12. Lan Q, Zheng T, Chanock S, et al. Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma. Carcinogenesis 2007;28:823-7.
13. Cox A, Dunning AM, Garcia-Closas M, et al. A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet 2007;39:352-8.
14. Sun T, Gao Y, Tan W, et al. A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers. Nat Genet 2007;39:605-13.
15. Rajaraman P, Wang SS, Rothman N, et al. Polymorphisms in apoptosis and cell cycle control genes and risk of brain tumors in adults. Cancer Epidemiol Biomarkers Prev 2007;16:1655-61.
16. Frank B, Rigas SH, Bermejo JL, et al. The CASP8 -652 6N del promoter polymorphism and breast cancer risk: a multicenter study. Breast Cancer Res Treat 2008;111:139-44.
17. Chenevix-Trench G, Milne RL, Antoniou AC, Couch FJ, Easton DF, Goldgar DE. An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA). Breast Cancer Res 2007;9:104.
18. Antoniou AC, Sinilnikova OM, Simard J, et al. RAD51 135G->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. Am J Hum Genet 2007;81:1186-200.
19. Gaudet M, Fara AG, Beritognolo I, Sabatti M. Allele-specific PCR in SNP genotyping. Methods Mol Biol 2009;578:415-24.
20. Antoniou AC, Goldgar DE, Andrieu N, et al. A weighted cohort approach for analysing factors modifying disease risks in carriers of high-risk susceptibility genes. Genet Epidemiol 2005;29:1-11.
21. Antoniou AC, Rookus M, Andrieu N, et al. Reproductive and hormonal factors, and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: results from the International BRCA1/2 Carrier Cohort Study. Cancer Epidemiol Biomarkers Prev 2009;18:601-10.
22. Antoniou A, Pharoah PD, Narod S, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 2003;72:1117-30.
23. Lin DY, Wej LJ. The robust inference for the Cox proportional hazards model. J Am Stat Assoc 1989;84:1074-78.
24. Palanca Suela S, Esteban Cardenosa E, Barragan Gonzalez E, et al. CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and BRCA2 carriers. Breast Cancer Res Treat; 119:87-93.
25. Wang X, Pankratz VS, Fredericksen Z, et al. Common variants associated with breast cancer in genome wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers. Hum Mol Genet 2010;19:2886-97.
26. Shephard ND, Abo R, Rigas SH, et al. A breast cancer risk haplotype in the caspase-8 gene. Cancer Res 2009;69:2724-8.
27. Ramus SJ, Vierkant RA, Johnatty SE, et al. Consortium analysis of 7 candidate SNPs for ovarian cancer. Int J Cancer 2008;123:380-8.
28. Latif A, McBurney HJ, Roberts SA, et al. Breast cancer susceptibility variants alter risk in familial ovarian cancer. Fam Cancer Epub 2010 May 26.
29. Milhas D, Cuvillier O, Therville N, et al. Caspase-10 triggers Bid cleavage and caspase cascade activation in FasL-induced apoptosis. J Biol Chem 2005;280:19836-42.
30. Gaudet MM, Milne RL, Cox A, et al. Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev 2009;18:1610-6.
31. Antoniou AC, Sinilnikova OM, McGuffog L, et al. Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. Hum Mol Genet 2009;18:4442-56.
32. Antoniou AC, Spurdle AB, Sinilnikova OM, et al. Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Am J Hum Genet 2008;82:937-48.